|
CWF19L2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.62447832963153E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
6.622400E-02 |
| Stage1-vs-Stage3 |
8.601900E-02 |
| Stage1-vs-Stage4 |
1.146620E-01 |
| Stage2-vs-Stage3 |
6.228400E-01 |
| Stage2-vs-Stage4 |
7.861200E-01 |
| Stage3-vs-Stage4 |
8.243200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
8.70309999623231E-08 |
| Normal-vs-Asian |
1.72184488889116E-12 |
| Caucasian-vs-AfricanAmerican |
2.472000E-01 |
| Caucasian-vs-Asian |
8.924200E-01 |
| AfricanAmerican-vs-Asian |
3.709400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.955390E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.60854999999849E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.138600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.333600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.119200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.185000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.331000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.372400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.349800E-02 |
| Classical-VS-Follicular |
8.098100E-03 |
| Classical-VS-Other |
3.592000E-01 |
| Classical-VS-Normal |
1.68809410894255E-12 |
| Tall-VS-Follicular |
9.269400E-01 |
| Tall-VS-Other |
9.476400E-01 |
| Tall-VS-Normal |
2.1316282072803E-14 |
| Follicular-VS-Other |
9.876800E-01 |
| Follicular-VS-Normal |
1.62436730732907E-12 |
| Other-VS-Normal |
7.92769999999887E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
4.44089209850063E-16 |
| N0-vs-N1 |
4.083000E-01 |
|
|
